![_CELL-24-005-Website-Refresh-graphics-PE-overview-icon-1 1 _CELL-24-005-Website-Refresh-graphics-PE-overview-icon-1 1](https://www.cellistic.com/hs-fs/hubfs/_CELL-24-005-Website-Refresh-graphics-PE-overview-icon-1%201.png?width=99&height=100&name=_CELL-24-005-Website-Refresh-graphics-PE-overview-icon-1%201.png)
Reduce Risk
With over +100 people focused in iPSC and a proven track record in delivering iPSC, your project is in safe hands
![_CELL-24-005-Website-Refresh-graphics-PE-overview-icon-2 4 _CELL-24-005-Website-Refresh-graphics-PE-overview-icon-2 4](https://www.cellistic.com/hs-fs/hubfs/_CELL-24-005-Website-Refresh-graphics-PE-overview-icon-2%204.png?width=100&height=100&name=_CELL-24-005-Website-Refresh-graphics-PE-overview-icon-2%204.png)
Save Time
You can skip time-consuming steps, with process development work already complete for key immunotherapy cell types
![_CELL-24-005-Website-Refresh-graphics-PE-overview-icon-3 1 _CELL-24-005-Website-Refresh-graphics-PE-overview-icon-3 1](https://www.cellistic.com/hs-fs/hubfs/_CELL-24-005-Website-Refresh-graphics-PE-overview-icon-3%201.png?width=100&height=100&name=_CELL-24-005-Website-Refresh-graphics-PE-overview-icon-3%201.png)
Limit Costs
Since every day in development has a cost attached, reducing your timeline to clinical drives bottom-line benefits
Seize a powerful advantage
Pulse + Echo have been designed and engineered to clear a path for cell therapy innovators intent to benefit on what iPSC-based allogeneic cell therapy can uniquely offer.
Reduce Risk
With over +100 people focused in iPSC and a proven track record in delivering iPSC, your project is in safe hands
Save Time
You can skip time-consuming steps, with process development work already complete for key immunotherapy cell types
Limit Costs
Since every day in development has a cost attached, reducing your timeline to clinical drives bottom-line benefits